[Title 21 CFR A]
[Code of Federal Regulations (annual edition) - April 1, 1996 Edition]
[Title 21 - FOOD AND DRUGS]
[Chapter I - FOOD AND DRUG ADMINISTRATION,]
[Subchapter F - BIOLOGICS]
[Part 650 - ADDITIONAL STANDARDS FOR DIAGNOSTIC SUBSTANCES FOR DERMAL TESTS]
[Subpart A - Diphtheria Toxin for Schick Test]
[From the U.S. Government Publishing Office]
21
FOOD AND DRUGS
7
1996-04-01
1996-04-01
false
Diphtheria Toxin for Schick Test
A
Subpart A
FOOD AND DRUGS
FOOD AND DRUG ADMINISTRATION,
BIOLOGICS
ADDITIONAL STANDARDS FOR DIAGNOSTIC SUBSTANCES FOR DERMAL TESTS
Subpart A--Diphtheria Toxin for Schick Test
Sec. 650.1 Diphtheria Toxin for Schick Test.
The proper name of this product shall be Diphtheria Toxin for Schick
Test, which shall be a preparation of a diphtheria toxin obtained from
the growth of Corynebacterium diphtheriae.
Sec. 650.2 U.S. Standard preparation.
The U.S. Standard Diphtheria Toxin for Schick Test shall be used to
determine the Schick test dose of the product. The Schick test dose of
the standard is that amount of the standard that, when mixed with 0.001
unit of the U.S. Standard Diphtheria Antitoxin and injected
intradermally in a guinea pig, will induce an erythematous reaction of
10 mm. in diameter.
Sec. 650.3 Manufacture of Diphtheria Toxin for Schick Test.
(a) Propagation of bacteria. The culture medium for propagation of
the Corynebacterium diphtheriae for preparation of the parent toxin
shall not contain ingredients known to be capable of producing
allergenic effects in human subjects.
(b) The parent toxin. Diphtheria Toxin for Schick Test shall be
prepared from a parent toxin which has been demonstrated to be stable
and which contains no less than 400 minimum lethal doses per milliliter
or 400,000 minimum reaction doses per milliliter. A minimum lethal dose
is the smallest amount of toxin that will kill a guinea pig weighing
approximately 250 gm. on the fourth day after its subcutaneous
injection. A minimum reaction dose is that amount of toxin which when
injected intradermally into a guinea pig induces an erythematous
reaction 10 mm. in diameter.
Sec. 650.4 Potency test.
The dermal reactivity of each lot of the product shall be determined
from the results of simultaneous guinea pig intradermal potency tests of
the product under test and of the standard. The test shall be performed
as follows:
(a) Guinea pigs. At least four healthy female guinea pigs shall be
used, all of the same strain and each of a size that will permit a
random distribution of eight intradermal injections. The hair shall be
removed from the back and both sides of each guinea pig without
producing abrasions of the skin. The denuded skin of each animal shall
be sectioned into four equal areas at right angles to the vertebral
column to provide two injection sites in each of the four areas, one on
each side of the vertebra. The test is not valid if the guinea pigs do
not show a graded response to the graded dilutions of the Schick test
dose of the standard toxin.
(b) Preparation of the test doses. Four dilutions, two of the
product under test and two of the U.S. Standard Diphtheria Toxin for
Schick Test, shall be prepared in sterile buffered saline pH 7.4
containing 0.2 percent gelatin. The low and high dilutions of the
standard shall be those amounts of a Schick test dose of the standard
which in a dose of 0.1 ml. are capable of eliciting graded erythematous
dermal reactions between 10 mm. and 20 mm. in diameter. The low and high
dilutions of the Schick test dose of the toxin under test shall be the
same as those of the standard toxin and estimated to have the same
dermal reactivity.
(c) Inoculation. The low and high dilutions of the product (chart
designation PL and PH) and the low and high dilutions of the
standard (chart designations SL and SH) shall be injected
intradermally in a volume of 0.1 ml. into each of the four guinea pigs
according to either the following scheme, or in another scheme, provided
it will permit comparable randomization of injection sites:
----------------------------------------------------------------------------------------------------------------
Guinea Pig Number
----------------------------------------------------------------------------------
Area 1 2 3 4
----------------------------------------------------------------------------------
Left Right Left Right Left Right Left Right
----------------------------------------------------------------------------------------------------------------
A............................ SL SL SH SH PL PL PH PH
B............................ SH SH SL SL PH PH PL PL
[[Page 147]]
C............................ PL PL PH PH SL SL SH SH
D............................ PH PH PL PL SH SH SL SL
----------------------------------------------------------------------------------------------------------------
(d) Calculation of test results. Between 40 and 66 hours following
injection, a diameter of the reaction for each injection site shall be
calculated by averaging two diameters of the reaction measured at right
angles to each other. The average reaction for each dilution for each
animal shall be determined, then the average diameters of the reactions
of all of the guinea pigs for each dilution shall be calculated. The
ratios of the reactions are determined by dividing the average diameter
of the low dilution of the product under test by the average diameter of
the low dilution of the standard and by dividing the average diameter of
the high dilution of the product by the average diameter of the high
dilution of the standard.
(e) Potency requirement. The potency of the product under test is
satisfactory if each calculated ratio of the reactions of the product
under test and of the standard is 1.0. The potency of the lot under test
is considered to be equal to that of the standard if the ratios are not
lower than 0.77 or higher than 1.30, provided that in a single test the
ratios are substantially the same.
Sec. 650.5 Stability test.
A sample of each lot of the product shall be held at 37 deg. C for
not less than 24 hours and then tested for potency as prescribed in
Sec. 650.4. The stability of the product is satisfactory if test results
of the sample meet the potency requirement prescribed in Sec. 650.4(e).
Sec. 650.6 Samples; protocols; official release.
For each lot of the product, the following material shall be
submitted to the Director, Center for Biologics Evaluation and Research:
(a) A protocol which consists of a summary of the history of
manufacture of each lot including all results of all tests for which
test results are requested by the Director, Center for Biologics
Evaluation and Research.
(b) A sample of no less than 20 milliliters of the product.
(c) The product shall not be issued by the manufacturer until
written notification of official release of the lot is received from the
Director, Center for Biologics Evaluation and Research.
[38 FR 32097, Nov. 20, 1973, as amended at 42 FR 27584, May 31, 1977; 49
FR 23834, June 8, 1984; 55 FR 11013, Mar. 26, 1990]